Ratio Analysis: Unpacking Ocular Therapeutix Inc (OCUL)’s Price-to-Cash and Price-to-Free Cash Flow
Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth. After finishing at $5.86 in the prior trading day, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $5.22, down -10.92%. In other words, the price has decreased by -$10.92 from its previous […]
Ocular Therapeutix Inc (OCUL)’s financial ratios: A comprehensive overview
In the latest session, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $7.79 down -0.13% from its previous closing price of $7.80. On the day, 1343238 shares were traded. Ratios: For a deeper understanding of Ocular Therapeutix Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio […]
Ocular Therapeutix Inc (OCUL) Shares Decline by -5.33% to Close at $7.99
As of close of business last night, Ocular Therapeutix Inc’s stock clocked out at $7.99, down -5.33% from its previous closing price of $8.44. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 2125410 shares were traded. OCUL stock price reached its highest trading level at $8.86 […]
Ocular Therapeutix Inc (OCUL)’s financial ratios: A comprehensive overview
The closing price of Ocular Therapeutix Inc (NASDAQ: OCUL) was $9.10 for the day, down -2.26% from the previous closing price of $9.31. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 2199073 shares were traded. Ratios: Our analysis of OCUL’s different ratios will help us gain […]
Ocular Therapeutix Inc (OCUL)’s financial ratios: A comprehensive overview
The price of Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $9.49 in the last session, down -6.50% from day before closing price of $10.15. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 1417880 shares were traded. Ratios: We take a closer look at OCUL’s different ratios […]
Ocular Therapeutix Inc (OCUL) stock: analyst predictions for current quarter EPS
After finishing at $9.46 in the prior trading day, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $9.44, down -0.21%. In other words, the price has decreased by -$0.02 from its previous closing price. On the day, 1760355 shares were traded. OCUL stock price reached its highest trading level at $9.63 during the session, while it […]
Ocular Therapeutix Inc (OCUL) Stocks Reach New Highs at $9.98 During Trading Session
After finishing at $10.37 in the prior trading day, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $9.98, down -3.76%. On the day, 2041320 shares were traded. OCUL stock price reached its highest trading level at $10.65 during the session, while it also had its lowest trading level at $9.88. Ratios: Our goal is to gain […]
Ocular Therapeutix Inc (OCUL) Moving Averages: Key Indicators for Technical Analysis.
The price of Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $10.83 in the last session, down -0.91% from day before closing price of $10.93. On the day, 2999647 shares were traded. Ratios: We take a closer look at OCUL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), […]
Understanding Ocular Therapeutix Inc (OCUL) through its ratios
In the latest session, Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $9.95 up 0.51% from its previous closing price of $9.90. In other words, the price has increased by $+0.05 from its previous closing price. On the day, 2832958 shares were traded. Ratios: For a deeper understanding of Ocular Therapeutix Inc’s stock, let’s take a […]
Ocular Therapeutix Inc (OCUL)’s financial ratios: A comprehensive overview
In other words, the price has increased by $0.00 from its previous closing price. On the day, 2737352 shares were traded. Ratios: For a better understanding of OCUL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.96 and its Current Ratio is at 4.03. In the meantime, […]
